Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

PARP Inhibitors and Parkinson's Disease.

Olsen AL, Feany MB.

N Engl J Med. 2019 Jan 31;380(5):492-494. doi: 10.1056/NEJMcibr1814680. No abstract available.

PMID:
30699325
2.

Comparison of catheter thrombogenicity in a modified chandler loop model using goat blood.

Olsen AL, Long M.

J Biomed Mater Res A. 2018 Dec;106(12):3143-3151. doi: 10.1002/jbm.a.36509. Epub 2018 Sep 7.

PMID:
30194709
3.

Functional Genomics and Immunologic Tools: The Impact of Viral and Host Genetic Variations on the Outcome of Zika Virus Infection.

Yun SI, Song BH, Frank JC, Julander JG, Olsen AL, Polejaeva IA, Davies CJ, White KL, Lee YM.

Viruses. 2018 Aug 11;10(8). pii: E422. doi: 10.3390/v10080422.

4.

Discovering New Benefits From Old Drugs With Big Data-Promise for Parkinson Disease.

Olsen AL, Riise T, Scherzer CR.

JAMA Neurol. 2018 Aug 1;75(8):917-920. doi: 10.1001/jamaneurol.2018.0345. No abstract available.

PMID:
29710184
5.

PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation.

Ronson GE, Piberger AL, Higgs MR, Olsen AL, Stewart GS, McHugh PJ, Petermann E, Lakin ND.

Nat Commun. 2018 Feb 21;9(1):746. doi: 10.1038/s41467-018-03159-2.

6.

The fibronectin ED-A domain enhances recruitment of latent TGF-β-binding protein-1 to the fibroblast matrix.

Klingberg F, Chau G, Walraven M, Boo S, Koehler A, Chow ML, Olsen AL, Im M, Lodyga M, Wells RG, White ES, Hinz B.

J Cell Sci. 2018 Mar 1;131(5). pii: jcs201293. doi: 10.1242/jcs.201293.

7.

The Influence of Oblique Angle Forced Exercise in Surgically Destabilized Stifle Joints Is Synergistic with Bone, but Antagonistic with Cartilage in an Ovine Model of Osteoarthritis.

Hill RJ, Mason HM, Yeip G, Merchant SS, Olsen AL, Stott RD, Van Wettere AJ, Bressel E, Mason JB.

Arthritis. 2017;2017:7481619. doi: 10.1155/2017/7481619. Epub 2017 Feb 27.

8.

Fibronectin Extra Domain A Promotes Liver Sinusoid Repair following Hepatectomy.

Sackey-Aboagye B, Olsen AL, Mukherjee SM, Ventriglia A, Yokosaki Y, Greenbaum LE, Lee GY, Naga H, Wells RG.

PLoS One. 2016 Oct 14;11(10):e0163737. doi: 10.1371/journal.pone.0163737. eCollection 2016.

9.

Patient education and basic body awareness therapy in hip osteoarthritis - a qualitative study of patients' movement learning experiences.

Olsen AL, Strand LI, Skjaerven LH, Sundal MA, Magnussen LH.

Disabil Rehabil. 2017 Aug;39(16):1631-1638. doi: 10.1080/09638288.2016.1209578. Epub 2016 Aug 5.

PMID:
27494177
10.

Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1.

Polejaeva IA, Ranjan R, Davies CJ, Regouski M, Hall J, Olsen AL, Meng Q, Rutigliano HM, Dosdall DJ, Angel NA, Sachse FB, Seidel T, Thomas AJ, Stott R, Panter KE, Lee PM, Van Wettere AJ, Stevens JR, Wang Z, MacLeod RS, Marrouche NF, White KL.

J Cardiovasc Electrophysiol. 2016 Oct;27(10):1220-1229. doi: 10.1111/jce.13049. Epub 2016 Aug 30.

11.

Response to Protocol Review Scenario: The details are what matter.

Schmidt RH, Olsen AL.

Lab Anim (NY). 2016 Mar;45(3):96-7. doi: 10.1038/laban.951. No abstract available.

PMID:
26886671
12.

Patients suffering from rheumatic disease describing own experiences from participating in Basic Body Awareness Group Therapy: A qualitative pilot study.

Olsen AL, Skjaerven LH.

Physiother Theory Pract. 2016;32(2):98-106. doi: 10.3109/09593985.2015.1115568. Epub 2016 Feb 10.

PMID:
26863582
13.

Cerebral perfusion in stroke-like migraine attacks after radiation therapy syndrome.

Olsen AL, Miller JJ, Bhattacharyya S, Voinescu PE, Klein JP.

Neurology. 2016 Feb 23;86(8):787-9. doi: 10.1212/WNL.0000000000002400. Epub 2016 Jan 27. No abstract available.

PMID:
26819456
14.

Caspr2 autoantibodies target multiple epitopes.

Olsen AL, Lai Y, Dalmau J, Scherer SS, Lancaster E.

Neurol Neuroimmunol Neuroinflamm. 2015 Jul 2;2(4):e127. doi: 10.1212/NXI.0000000000000127. eCollection 2015 Aug.

15.

[Eating disorder in a nineteen months-old girl and associated mother child relationship disturbance].

Olsen AL, Sigvard AM, Skovgaard AM.

Ugeskr Laeger. 2015 Jan 26;177(2A):76-7. Danish.

PMID:
25612977
16.

Diagnostic imaging and pacemaker implantation in a domestic goat with persistent left cranial vena cava.

Ranjan R, Dosdall D, Norlund L, Higuchi K, Silvernagel JM, Olsen AL, Davies CJ, MacLeod R, Marrouche NF.

J Vet Cardiol. 2014 Mar;16(1):45-50. doi: 10.1016/j.jvc.2013.11.001. Epub 2013 Dec 25.

17.

Quantitative analysis of survivin protein expression and its therapeutic depletion by an antisense oligonucleotide in human lung tumors.

Olsen AL, Davies JM, Medley L, Breen D, Talbot DC, McHugh PJ.

Mol Ther Nucleic Acids. 2012 Jun 19;1:e30. doi: 10.1038/mtna.2012.19.

18.

Isolation of rat portal fibroblasts by in situ liver perfusion.

Wen JW, Olsen AL, Perepelyuk M, Wells RG.

J Vis Exp. 2012 Jun 29;(64). pii: 3669. doi: 10.3791/3669.

19.

Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts.

Olsen AL, Sackey BK, Marcinkiewicz C, Boettiger D, Wells RG.

Gastroenterology. 2012 Apr;142(4):928-937.e3. doi: 10.1053/j.gastro.2011.12.038. Epub 2011 Dec 24.

20.

Peripheral immunization induces functional intrahepatic hepatitis C specific immunity following selective retention of vaccine-specific CD8 T cells by the liver.

Lang Kuhs KA, Toporovski R, Ginsberg AA, Olsen AL, Shedlock DJ, Morrow MP, Yan J, Wells RG, Weiner DB.

Hum Vaccin. 2011 Dec;7(12):1326-35. doi: 10.4161/hv.7.12.18279. Epub 2011 Dec 1.

21.

Hepatic stellate cells require a stiff environment for myofibroblastic differentiation.

Olsen AL, Bloomer SA, Chan EP, Gaça MD, Georges PC, Sackey B, Uemura M, Janmey PA, Wells RG.

Am J Physiol Gastrointest Liver Physiol. 2011 Jul;301(1):G110-8. doi: 10.1152/ajpgi.00412.2010. Epub 2011 Apr 28.

22.

Long-term prognosis for children with breath-holding spells.

Olsen AL, Mathiasen R, Rasmussen NH, Knudsen FU.

Dan Med Bull. 2010 Nov;57(11):A4217.

PMID:
21055373
23.

Tumor survivin is downregulated by the antisense oligonucleotide LY2181308: a proof-of-concept, first-in-human dose study.

Talbot DC, Ranson M, Davies J, Lahn M, Callies S, André V, Kadam S, Burgess M, Slapak C, Olsen AL, McHugh PJ, de Bono JS, Matthews J, Saleem A, Price P.

Clin Cancer Res. 2010 Dec 15;16(24):6150-8. doi: 10.1158/1078-0432.CCR-10-1932. Epub 2010 Nov 1. Erratum in: Clin Cancer Res. 2011 Apr 15;17(8):2602.

24.

XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.

Bhagwat N, Olsen AL, Wang AT, Hanada K, Stuckert P, Kanaar R, D'Andrea A, Niedernhofer LJ, McHugh PJ.

Mol Cell Biol. 2009 Dec;29(24):6427-37. doi: 10.1128/MCB.00086-09. Epub 2009 Oct 5.

25.

Effect of music therapy on anxiety and depression in patients with Alzheimer's type dementia: randomised, controlled study.

Guétin S, Portet F, Picot MC, Pommié C, Messaoudi M, Djabelkir L, Olsen AL, Cano MM, Lecourt E, Touchon J.

Dement Geriatr Cogn Disord. 2009;28(1):36-46. doi: 10.1159/000229024. Epub 2009 Jul 23.

PMID:
19628939
26.

Nosocomial infection in a Danish Neonatal Intensive Care Unit: a prospective study.

Olsen AL, Reinholdt J, Jensen AM, Andersen LP, Jensen ET.

Acta Paediatr. 2009 Aug;98(8):1294-9. doi: 10.1111/j.1651-2227.2009.01322.x. Epub 2009 May 12.

PMID:
19438843
27.

Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus.

Subramanian GM, Moore PA, Gowen BB, Olsen AL, Barnard DL, Paragas J, Hogan RJ, Sidwell RW.

Chemotherapy. 2008;54(3):176-80. doi: 10.1159/000140361. Epub 2008 Jun 18.

PMID:
18560223
28.

West Nile virus-induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neurons.

Morrey JD, Siddharthan V, Wang H, Hall JO, Skirpstunas RT, Olsen AL, Nordstrom JL, Koenig S, Johnson S, Diamond MS.

J Neurovirol. 2008 Apr;14(2):152-63. doi: 10.1080/13550280801958930.

29.

Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents.

Morrey JD, Olsen AL, Siddharthan V, Motter NE, Wang H, Taro BS, Chen D, Ruffner D, Hall JO.

J Gen Virol. 2008 Feb;89(Pt 2):467-73. doi: 10.1099/vir.0.83345-0.

PMID:
18198377
30.

Clinical predictors of urinary retention after pelvic reconstructive and stress urinary incontinence surgery.

Komesu YM, Rogers RG, Kammerer-Doak DN, Olsen AL, Thompson PK, Walters MD.

J Reprod Med. 2007 Jul;52(7):611-5.

PMID:
17853529
31.

Posterior repair and sexual function.

Komesu YM, Rogers RG, Kammerer-Doak DN, Barber MD, Olsen AL.

Am J Obstet Gynecol. 2007 Jul;197(1):101.e1-6.

32.

Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model.

Morrey JD, Siddharthan V, Olsen AL, Wang H, Julander JG, Hall JO, Li H, Nordstrom JL, Koenig S, Johnson S, Diamond MS.

Antimicrob Agents Chemother. 2007 Jul;51(7):2396-402. Epub 2007 Apr 23.

33.

Correlation between breakdown of the blood-brain barrier and disease outcome of viral encephalitis in mice.

Olsen AL, Morrey JD, Smee DF, Sidwell RW.

Antiviral Res. 2007 Aug;75(2):104-12. Epub 2006 Dec 20.

34.

Prophylactic treatment with recombinant Eimeria protein, alone or in combination with an agonist cocktail, protects mice from Banzi virus infection.

Julander JG, Judge JW, Olsen AL, Rosenberg B, Schafer K, Sidwell RW.

Antiviral Res. 2007 Jul;75(1):14-9. Epub 2006 Dec 4.

35.

Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters.

Morrey JD, Siddharthan V, Olsen AL, Roper GY, Wang H, Baldwin TJ, Koenig S, Johnson S, Nordstrom JL, Diamond MS.

J Infect Dis. 2006 Nov 1;194(9):1300-8. Epub 2006 Sep 22.

PMID:
17041857
36.

Designer blood: creating hematopoietic lineages from embryonic stem cells.

Olsen AL, Stachura DL, Weiss MJ.

Blood. 2006 Feb 15;107(4):1265-75. Epub 2005 Oct 27. Review.

37.

Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival.

Julander JG, Winger QA, Olsen AL, Day CW, Sidwell RW, Morrey JD.

Antiviral Res. 2005 Feb;65(2):79-85.

PMID:
15708634
38.

Vaginal pessaries for the management of stress and mixed urinary incontinence.

Donnelly MJ, Powell-Morgan S, Olsen AL, Nygaard IE.

Int Urogynecol J Pelvic Floor Dysfunct. 2004 Sep-Oct;15(5):302-7. Epub 2004 Aug 5.

PMID:
15300365
39.

Modeling hamsters for evaluating West Nile virus therapies.

Morrey JD, Day CW, Julander JG, Olsen AL, Sidwell RW, Cheney CD, Blatt LM.

Antiviral Res. 2004 Jul;63(1):41-50.

PMID:
15196819
40.

Pelvic floor nerve conduction studies: establishing clinically relevant normative data.

Olsen AL, Ross M, Stansfield RB, Kreiter C.

Am J Obstet Gynecol. 2003 Oct;189(4):1114-9.

PMID:
14586364
41.

Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery.

Mazarakis ND, Azzouz M, Rohll JB, Ellard FM, Wilkes FJ, Olsen AL, Carter EE, Barber RD, Baban DF, Kingsman SM, Kingsman AJ, O'Malley K, Mitrophanous KA.

Hum Mol Genet. 2001 Sep 15;10(19):2109-21.

PMID:
11590128
42.

Clinical neurophysiology and electrodiagnostic testing of the pelvic floor.

Olsen AL, Rao SS.

Gastroenterol Clin North Am. 2001 Mar;30(1):33-54, v-vi. Review.

PMID:
11394036
43.

Urethral sphincter needle electromyography in women: comparison of periurethral and transvaginal approaches.

Olsen AL, Benson JT, McClellan E.

Neurourol Urodyn. 1998;17(5):531-5.

PMID:
9776016
44.

LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing.

Screaton GR, Xu XN, Olsen AL, Cowper AE, Tan R, McMichael AJ, Bell JI.

Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4615-9.

45.

Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence.

Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL.

Obstet Gynecol. 1997 Apr;89(4):501-6.

PMID:
9083302
46.

Genetic analysis of phoP and ompR from Yersinia enterocolitica, Yersinia pseudotuberculosis and Yersinia pestis.

Wren BW, Olsen AL, Stabler R, Li SR.

Contrib Microbiol Immunol. 1995;13:318-20. No abstract available.

PMID:
8833862
47.

A PCR-based strategy for the construction of a defined Yersinia enterocolitica O:8 htrA mutant.

Wren BW, Olsen AL, Stabler R, Li SR.

Contrib Microbiol Immunol. 1995;13:290-3. No abstract available.

PMID:
8833856
48.

Transmittance of cupric chloride solutions at elevated temperatures.

Olsen AL, Nichols LW, Rogers AK.

Appl Opt. 1972 Apr 1;11(4):954. doi: 10.1364/AO.11.000954. No abstract available.

PMID:
20119079
49.

Modification of the infrared source circuit in the cary model 14 spectrophotometer.

Olsen AL, Nichols LW.

Appl Opt. 1970 Nov 1;9(11):2585. doi: 10.1364/AO.9.002585. No abstract available.

PMID:
20094313
50.

Polarization in Cary model 14 spectrophotometers and its effect on transmittance measurements of anisotropic materials.

Hills ME, Olsen AL, Nichols LW.

Appl Opt. 1968 Aug 1;7(8):1437-41. doi: 10.1364/AO.7.001437.

PMID:
20068821

Supplemental Content

Loading ...
Support Center